Syros

+$0.18 (+4.95%) Today
+$0.32 (+8.38%) As of 12:05 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Syros and other ETFs, options, and stocks.

About SYRS

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609.

CEO
Nancy A. Simonian
Employees
103
Headquarters
Cambridge, Massachusetts
Founded
2011

SYRS Key Statistics

Market cap
236.64M
Price-Earnings ratio
—
Dividend yield
—
Average volume
424.64K
High today
$3.90
Low today
$3.61
Open price
$3.68
Volume
300.93K
52 Week high
$15.65
52 Week low
$3.61

SYRS Earnings

-$0.62
-$0.41
-$0.21
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure